Family History of Autoimmune Thyroid Disease
https://doi.org/10.14341/ket20139439-45
Abstract
The aim of this study was estimate the clinical characteristics of Graves' disease (GD) and Hashimoto's thyroiditis (HT) in first@degree relatives of persons in families with autoimmune thyroid diseases (AITD). Patients: Eighty one patients with AITD of 40 families, mean age (+/@s.d.) 41.9 ± 1.8; range 18-73 years. In 10 families (25%) AITD traced among siblings, whose average age was 33.6 ± 3.5 years, 29 families (72.5%) - of two generations (parent@ descendant) 57.4 ± 1.6 and 32.2 ± 1.5 years, p = 0.001, respectively. In one family (2.5%) the disease was traced in both parents and their offspring. Results. Among patients with a positive family history for AITD is dominated by a pair of parent - descendant with a diagnosis of hypothyroidism (55%). Preliminary evidence of genetic anticipation in GD and HT. Patients with a family history of AITD ill of GD and HT to 50 years (84%), half - up to 30 years (47%). In familial forms of GD, a decrease in compensated patients for two generations. Among parents and descendant with hypothyroidism, there is a low percentage of persons over the medical euthyroidism (42%).
About the Authors
O Rymardoktor med. nauk, vedushchiy nauchnyy sotrudnik laboratorii kliniko-populyatsionnykh i profilakticheskikh issledovaniy terapevticheskikh i endokrinnykh zabolevaniy FGBU “NII terapii” SO RAMN
A Pyankova
zaochnyy aspirant FGBU “NII terapii” SO RAMN
V Maksimov
doktor med. nauk, zav. laboratoriey molekulyarno-geneticheskikh issledovaniy terapevticheskikh zabolevaniy FGBU “NII terapii” SO RAMN
S Mustafina
kand. med. nauk, starshiy nauchnyy sotrudnik laboratorii kliniko-populyatsionnykh i profilakticheskikh issledovaniy terapevticheskikh i endokrinnykh zabolevaniy FGBU “NII terapii” SO RAMN
References
1. Ванушко ВЭ, Фадеев ВВ. Болезнь Грейвса (клиническая лекция). Эндокринная хирургия. 2013;4:23-33.
2. Моргунова Т, Мануйлова Ю, Фадеев В. Медико-социальные аспекты заместительной терапии гипотиреоза: факторы, влияющие на качество компенсации. Клиническая и экспериментальная тиреоидология. 2007;3:12-25.
3. Никитин ЮП, Рымар ОД, Максимов ВН и др. Полиморфизм A49G гена цитотоксического Т-лимфоцит-связанного иммуноглобулина 4 (CTLA4), связь с аутоиммунными заболеваниями щитовидной железы в популяции Новосибирска. Клиническая и экспериментальная тиреоидология. 2008; 4(4):41-45.
4. Никитин ЮП, Рымар ОД, Максимов ВН и др. Полиморфизм G(-308) А гена TNF-альфа, связь с аутоиммунными заболеваниями щитовидной железы в популяции Новосибирска. Бюллетень Сибирского отделения Российской академии медицинских наук. 2009;69-73.
5. Никитин ЮП, Рымар ОД, Максимов ВН и др. Связь полиморфизма C1858T гена PTPN22 с аутоиммунным тиреоидитом с исходом в гипотиреоз в популяции Новосибирска. Клиническая и экспериментальная тиреоидология. 2009; 5(1):47-52.
6. Рымар ОД, Мустафина СВ, Рагино ЮИ, Щербакова ЛВ. Уровни антител к тиреоидной пероксидазе в зависимости от пола и возраста в подвыборке мужчин и женщин 25-69 лет Новосибирска (эпидемиологиское исследование). Бюллетень Сибирского отделения Российской академии медицинских наук. 2009;69-73.
7. Рымар ОД, Микитинская АК, Максимов ВН. Роль генетических факторов в этиологии аутоиммунных заболеваний щитовидной железы. Сибирский медицинский журнал. 2011;26(4/2):34-41.
8. Рымар ОД, Мустафина СВ, Симонова ГИ и др. Эпидемиологические исследования йодного дефицита и тиреоидной патологии в крупном центре Западной Сибири 1995-2010 гг. (на примере г. Новосибирска). Клиническая и экспериментальная тиреоидология. 2012;8(2):50-54.
9. Ando T, Imaizumi M, Graves PN et al. Intrathyroidal fetal microchimerism in Graves' disease. J Clin Endocrinol Metab. 2002;87:3315-3320.
10. Brent GA. Graves' disease. New Engl J Med. 2008;358:2544-2554.
11. Brix T, Hegedus L. Twin studies as a model for exploring the etiology of autoimmune thyroid disease. Clin Endocrinol. 2012; 76:457-464.
12. Brix TH, Petersen HC, Iachine I et al. Preliminary evidence of genetic anticipation in Graves' disease. Thyroid. 2003;13:447-451.
13. Dittmar M, Libich C, Brenzel T. Increased familial clustering of autoimmune thyroid diseases. Hormone and Metabolic Research. 2011;43:200-204.
14. Effraimidis G, Strieder TG, Tijssen JG, Wiersinga WM. Natural history of the transition from euthyroidism to overt autoimmune hypo@ or hyperthyroidism: a prospective study. Eur J Endocrinol. 2011;164:107-113.
15. Eschler D, Hasham A, Tomer Y. Cutting edge: the etiology of autoimmune thyroid diseases. Clinical reviews in allergy & Immunology. 2011;41:190-197.
16. Hemminki K, Li X, Sundquist J et al. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. Journal of Autoimmunity. 2010;34:307-313.
17. Hou X, Li Y, Li J et al. Development of thyroid dysfunction and autoantibodies in Graves' multiplex families: an eight-year follow-up study in Chinese Han pedigrees. Thyroid. 2011;21:1353-1358.
18. Klintschar M, Immel UD, Kehlen A et al. Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach. Eur J Endocrinol. 2006;154:237-241.
19. Lambert NC, Evans PC, Hashizumi TL et al. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J Immunol. 2000;164:5545-5548.
20. Manji N, Carr Smith JD, Boelaert K et al. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab. 2006;91:4873-4880.
21. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocrine Reviews. 2003;24:802-835.
22. Ringold DA, Nicoloff JT, Kesler M. Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid. 2000;12:647-653.
23. Sarkar K, Miller FW. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmunity Reviews. 2004;3:454-463.
24. Terry FD. Editorial: X versus X - the fight for function within the female cell and the development of autoimmune thyroid disease. J Clin Endocrinol Metab. 2005;90:6332-6333.
25. Tomer Y, Davies T. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocrine Reviews. 2003;24:694-717.
26. Vanderpump MPJ. The epidemiology of thyroid disease. British Medicine Bulletin. 2011;99:39-51.
27. Vos XG, Endert E, Tijssen JGP, Wiersinga WM. Genotypes in relation to phenotypic appearance and exposure to environmental factors in Graves' hyperthyroidism. Eur J Endocrinol. 2012;783-792.
28. Vos XG, Smit N., Endert E et al. Variation in phenotypic appearance of Graves' disease: effect of genetic anticipation and duration of complaints. Eur J Endocrinol. 2009;161:113-118.
29. Waldorf K, Nelson J. Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy. Immunol Invest. 2008;37:631-644.
30. Wei B, Peng Q, Zhang Q et al. Identification of a combination of SNPs associated with Graves' disease using swarm intelligence. Science China Life Science. 2011;54:139-145.
Review
For citations:
, , , Family History of Autoimmune Thyroid Disease. Clinical and experimental thyroidology. 2013;9(4):39-45. (In Russ.) https://doi.org/10.14341/ket20139439-45
Views:
672
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
